ABBOTT LABORATORIES Restructuring Reserve
ABBOTT LABORATORIES (ABT) had Restructuring Reserve of $58.00 million as of 2021-03-31, per its 10-Q filed 2021-05-05.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2021-05-05
- 2021-03-31: Restructuring Reserve $58.00M.
- 2020-12-31: Restructuring Reserve $70.00M.
- 2019-12-31: Restructuring Reserve $79.00M.
- 2018-12-31: Restructuring Reserve $70.00M.
| Period end | Restructuring Reserve |
|---|---|
| 2021-03-31 | $58.00M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $70.00M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $79.00M 10-K · filed 2021-02-19 |
| 2018-12-31 | $70.00M 10-K · filed 2021-02-19 |
| 2017-12-31 | $119.00M 10-K · filed 2021-02-19 |
| 2011-09-30 | $122.00M 10-Q · filed 2011-11-04 |
| 2010-12-31 | $77.00M 10-Q · filed 2011-11-04 |
| 2010-09-30 | $49.00M 10-Q · filed 2011-11-04 |
| 2009-12-31 | $145.00M 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |